Sanofi MS drug under safety review in the EU for dangerous side effects

The European Medicines Agency is taking a closer look at safety issues linked to the use of a Sanofi multiple sclerosis drug, Lemtrada.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news